Compounded GLP-1 weight loss, prescribed online.

Compounded semaglutide is not the same as Wegovy® and is not a generic version of it. Wegovy® is an FDA-approved finished drug product manufactured by Novo Nordisk. Compounded semaglutide is a non-FDA-approved preparation containing the peptide semaglutide, prepared by a state-licensed US compounding pharmacy under an individual prescription from a licensed US provider. Compounded preparations have not been clinically studied as finished products. Your licensed provider will review risks, benefits, and considerations with you before prescribing.

Brand-name Wegovy pricing reflects manufacturer R&D, marketing, distribution, and pharmacy markups. Compounded semaglutide is prepared directly by a state-licensed compounding pharmacy under an individual prescription, which removes those layers. REMEVi passes the savings to patients while keeping a US-licensed provider and a bilingual care coordinator in the loop month-over-month.

You can start within 24 hours of completing your intake. We recommend timing your first REMEVi shipment to arrive just as your Wegovy supply runs out. Once you've confirmed REMEVi is working for you, you can cancel Wegovy through your pharmacy or insurance.

Compounded medications are prepared under FDA regulations by licensed 503B pharmacies. While the final compounded product is not FDA-approved (unlike Wegovy), it is created to pharmaceutical standards and monitored by a licensed provider. REMEVi only partners with the highest-quality compounding pharmacies.

Most patients see results within 4–6 weeks, but everyone's body is different. Your REMEVi licensed provider monitors your progress monthly and can adjust your dose, timing, or medication to optimize results. We're committed to helping you reach your goals.